The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain

FASEB Journal

Volumn 24, Issue 12, 2010, Pages 4711-4721

  Martino, Mikaël M ^a   Hubbell, Jeffrey A ^a  

^a EPFL   (Switzerland)

Author keywords

Extracellular matrix; Heparin binding domain; Tissue engineering

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FIBRONECTIN III TYPE 12; FIBRONECTIN III TYPE 13; FIBRONECTIN III TYPE 14; NEUROTROPHIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; SPHEROID CELL; SURFACE PLASMON RESONANCE; TISSUE ENGINEERING;

CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBRONECTINS; HEPARIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649727712     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-151282     Document Type: Article

References (40)

1. Discher D. E., Mooney, D. J., and Zandstra, P. W. (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677
2. Schultz, G. S., and Wysocki, A. (2009) Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 17, 153-162
3. Macri, L., Silverstein, D., and Clark, R. A. (2007) Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv. Drug Deliv. Rev. 59, 1366-1381
4. Capila, I., and Linhardt, R. J. (2002) Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41, 391-412
5. Nugent, M. A., and Edelman, E. R. (1992) Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 31, 8876-8883
6. Maciag, T., Mehlman, T., Friesel, R., and Schreiber, A. B. (1984) Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 225, 932-935
7. McCaffrey, T. A., Falcone, D. J., and Du, B. (1992) Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J. Cell. Physiol. 152, 430-440
8. Sahni, A., Odrljin, T., and Francis, C. W. (1998) Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem. 273, 7554-7559
9. Peng, H., Sahni, A., Fay, P., Bellum, S., Prudovsky, I., Maciag, T., and Francis, C. W. (2004) Identification of a binding site on human FGF-2 for fibrinogen. Blood 103, 2114-2120
10. Noble, A., Towne, C., Chopin, L., Leavesley, D., and Upton, Z. (2003) Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration. Endocrinology 144, 2417-2424
11. Kricker, J. A., Towne, C. L., Firth, S. M., Herington, A. C., and Upton, Z. (2003) Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144, 2807-2815
12. Schoppet, M., Chavakis, T., Al-Fakhri, N., Kanse, S. M., and Preissner, K. T. (2002) Molecular interactions and functional interference between vitronectin and transforming growth factor-beta. Lab. Invest. 82, 37-46
13. Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M., and Wijelath, E. S. (2005) Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol. 6, 8
14. Sahni, A., Khorana, A. A., Baggs, R.. B., Peng, H., and Francis, C. W. (2006) FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood 107, 126-131
15. Mooradian, D. L., Lucas, R. C., Weatherbee, J. A., and Furcht, L. T. (1989) Transforming growth factor-beta-1 binds to immobilized fibronectin. J. Cell. Biochem. 41, 189-200
16. Xu, Q., Yan, B., Li, S., and Duan, C. (2004) Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration. J. Biol. Chem. 279, 4269-4277
17. Hoshijima, M., Hattori, T., Inoue, M., Araki, D., Hanagata, H., Miyauchi, A., and Takigawa, M. (2006) CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett. 580, 1376-1382
18. Smith, E. M., Mitsi, M., Nugent, M. A., and Symes, K. (2009) PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. Proc. Natl. Acad. Sci. U. S. A., 106, 21683-21688
19. Wijelath, E. S., Murray, J., Rahman, S., Patel, Y., Ishida, A., Strand, K., Aziz, S., Cardona, C., Hammond, W. P., Savidge, G. F., Rafii, S., and Sobel, M. (2002) Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res. 91, 25-31
20. Gui, Y. T., and Murphy, L. J. (2001) Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): Demonstration of IGF-I/IGFBP-3/FN ternary complexes in human plasma. J. Clin. Endocr. Metab. 86, 2104-2110
21. Martin, J. A., Miller, B. A., Scherb, M. B., Lembke, L. A., and Buckwalter, J. A. (2002) Co-localization of insulin-like growth factor binding protein 3 and fibronectin in human articular cartilage. Osteoarthritis Cartilage 10, 556-563
22. Bossard, C., Van den Berghe, L., Laurell, H., Castano, C., Cerutti, M., Prats, A. C., and Prats, H. (2004) Antiangiogenic properties of fibstatin, an extracellular FGF-2-binding polypeptide. Cancer Res. 64, 7507-7512
23. Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., Patel, Y., Suda, Y., Humphries, M. J., and Sobel, M. (2006) Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain - enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ. Res. 99, 853-860
24. Martino, M. M., Mochizuki, M., Rothenfluh, D. A., Rempel, S. A., Hubbell, J. A., and Barker, T. H. (2009) Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 30, 1089-1097
25. Schense, J. C., and Hubbell, J. A. (1999) Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10, 75-81
26. Zisch, A. H., Schenk, U., Schense, J. C., Sakiyama-Elbert, S. E., and Hubbell, J. A. (2001) Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Control. Release 72, 101-113
27. Korff, T., and Augustin, H. G. (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143, 1341-1352
28. Meijering, E., Jacob, M., Sarria, J. C., Steiner, P., Hirling, H., and Unser, M. (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58, 167-176 (Pubitemid 38509178)
29. Droguett, R., Cabello-Verrugio, C., Riquelme, C., and Brandan, E. (2006) Extracellular proteoglycans modify TGF-beta bioavailability attenuating its signaling during skeletal muscle differentiation. Matrix Biol. 25, 332-341
30. Mao, Y., and Schwarzbauer, J. E. (2005) Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 24, 389-399
31. Mitsi, M., Forsten-Williams, K., Gopalakrishnan, M., and Nugent, M. A. (2008) A catalytic role of heparin within the extracellular matrix. J. Biol. Chem. 283, 34796-34807
32. Mitsi, M., Hong, Z., Costello, C. E., and Nugent, M. A. (2006) Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry. 45, 10319-10328
33. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777
34. Ingham, K. C., Brew, S. A., and Atha, D. H. (1990) Interaction of heparin with fibronectin and isolated fibronectin domains. Biochem. J. 272, 605-611
35. Bultmann, H., Santas, A. J., and Peters, D. M. (1998) Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J. Biol. Chem. 273, 2601-2609
36. Barkalow, F. J., and Schwarzbauer, J. E. (1991) Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 266, 7812-7818
37. Patterson, J., Martino, M. M., and Hubbell, J. A. (2010) Biomimetic materials in tissue engineering. Mat. Today 13, 14-22
38. Mosher, D. F. (1976) Action of fibrin-stabilizing factor on cold-insoluble globulin and alpha2-macroglobulin in clotting plasma. J. Biol. Chem. 251, 1639-1645
39. Taylor, S. J., McDonald, J. W., 3rd, and Sakiyama-Elbert, S. E. (2004) Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control. Release 98, 281-294
40. Sakiyama-Elbert, S. E., and Hubbell, J. A. (2000) Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control. Release 69, 149-158